CLINICAL STUDY OF THE EFFECT OF XINGNAOJING COMBINED WITH EDARAVONE IN THE TREATMENT OF ACUTE CEREBRAL HEMORRHAGE
Dong Yan
Abstract
Dong Yan
Abstract
Objective To investigate the clinical effect of Xingnaojing combined with edaravone in the treatment of acute cerebral hemorrhage. Methods 95 patients with acute cerebral hemorrhage were randomly divided into two groups.The treatment group(n=50) were treated by Xingnaojing combined with edaravone,while the control group(n=45) were only treated with Xingnaojing.The treatment duration lasted 14 days for both groups.The total effective rates and neurological deficit score were compared. Results The total effective rate of treatment group(86.0%) was significantly better than that of control group(71.1%)(p0.05);The neurological deficit score of treatment group was significantly lower than that of control group after treatment(p0.05). Conclusion The treatment of Xingnaojing combined with edaravone has a good treatment effect on acute cerebral hemorrhage,safe and reliable.It is worthy of clinical application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the clinical effect of Xingnaojing combined with edaravone in the treatment of acute cerebral hemorrhage. Methods 95 patients with acute cerebral hemorrhage were randomly divided into two groups.The treatment group(n=50) were treated by Xingnaojing combined with edaravone,while the control group(n=45) were only treated with Xingnaojing.The treatment duration lasted 14 days for both groups.The total effective rates and neurological deficit score were compared. Results The total effective rate of treatment group(86.0%) was significantly better than that of control group(71.1%)(p0.05);The neurological deficit score of treatment group was significantly lower than that of control group after treatment(p0.05). Conclusion The treatment of Xingnaojing combined with edaravone has a good treatment effect on acute cerebral hemorrhage,safe and reliable.It is worthy of clinical application.
Key concepts: Edaravone, Medicine, Anesthesia, Neurological deficit, Clinical efficacy, Treatment and control groups, Conventional treatment, Therapeutic effect